Last $76.46 USD
Change Today -1.43 / -1.84%
Volume 406.7K
CLVS On Other Exchanges
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Erle T. Mast

Co-Founder, Chief Financial Officer and Executive Vice President, Clovis Oncology, Inc.
AgeTotal Calculated CompensationThis person is connected to 50 board members in 3 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Erle T. Mast co-founded Clovis Oncology, Inc. on April 20, 2009, and has been its Chief Financial Officer and Executive Vice President since April 20, 2009. Mr. Mast served as the Principal Accounting Officer and Secretary of Clovis Oncology, Inc. He served as the Chief Financial Officer of Pharmion LLC (formerly, Pharmion Corporation) from July 2002 to May 2008. He served as Principal Accounting Officer of Pharmion LLC until March 2008 and served as its Executive ...

Read Full Background

Corporate Headquarters*

2525 28th Street
Boulder, Colorado 80301

United States

Phone: 303-625-5000
Fax: 303-245-0360

Board Members Memberships*

Director, Chairman of Audit Committee and Member of Nominating/Corporate Governance Committee
Independent Director, Chairman of Audit Committee and Member of Nominating/Corporate Governance Committee
Director and Member of Audit Committee


California State University, Bakersfield

Other Affiliations*

Annual Compensation*

Total Annual Compensation$592,280

Stock Options*

All Other Compensation$15,255
Exercisable Options69,287
Exercisable Options Value$3,479,229
Unexercisable Options124,678
Unexercisable Options Value$5,112,087
Total Value of Options$8,591,315
Total Number of Options193,965

Total Compensation*

Total Annual Cash Compensation$607,535
Total Short Term Compensation$592,280
Other Long Term Compensation$15,255
Total Calculated Compensation$1,625,968
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $76.46 USD -1.43


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at